期刊文献+

基于lncRNA相关ceRNA网络预测冠心病血瘀证分子调控轴 被引量:1

Prediction on Molecular Regulation Axis of Coronary Heart Disease with Blood Stasis Syndrome Based on lncRNA-related ceRNA Network
下载PDF
导出
摘要 目的通过长链非编码RNA(lncRNA)相关竞争性内源RNA(ceRNA)网络构建及分析,探讨冠心病血瘀证发生发展机制。方法通过HMDD、DisGeNET、OMIM、GeneCards、TTD、lncRNADisease数据库查找冠心病血瘀证相关基因,并通过starBase平台构建lncRNA相关ceRNA网络,采用MCODE、MCL、GLay方法识别功能模块,基于最小结构熵确定最优模块识别方法,筛选包含lncRNA、miRNA、mRNA的模块,通过文献预测模块中潜在的调控轴。结果ceRNA网络共有283个节点,由72个miRNA、182个mRNA、29个lncRNA和4990个调控关系组成,共划分为11个功能模块,发现UCA1-miR-1-G6PD调控轴,其中miR-1抑制G6PD表达导致冠状动脉疾病的发生,而UCA1能够解除miR-1的抑制从而恢复G6PD正常表达。结论UCA1-miR-1-G6PD分子调控轴与冠心病血瘀证相关;可通过ceRNA网络的模块化分析开展病证相关研究。 Objective To discuss the mechanism of occurrence and development of blood stasis syndrome in coronary heart disease through the construction and analysis of lncRNA-related ceRNA network.Methods Related genes of the disease-coronary artery disease and the phenotypes in blood stasis syndrome were searched from HMDD,DisGeNET,OMIM,GeneCards,TTD,lncRNADisease databases,and lncRNA-related ceRNA network was constructed through starBase platform.The MCODE,MCL,GLay methods were used to identify functional modules and the optimal module identification based on minimal structural entropy was obtained.After that,the modules which contained lncRNA,miRNA,and mRNA were screened,and the potential regulatory axis was predicted through literature analysis.Results The ceRNA network had a total of 283 nodes,consisting of 72 miRNAs,182 mRNAs,29 lncRNAs and 4990 regulatory relationships.A total of 11 functional modules were obtained.The UCA1-miR-1-G6PD regulatory axis was found,among which hsa-miR-1 inhibited the expression of G6PD,leading to the cause of coronary artery disease,while UCA1 could relieve the inhibition of miR-1 and recover the normal expression of G6PD.Conclusion UCA1-miR-1-G6PD molecular regulatory axis is related to the pathogenesis of coronary heart disease with blood stasis syndrome,which can conduct disease-syndrome-related research through modular analysis of ceRNA network.
作者 王念 王博 冷媛媛 祁轶斐 李兵 张莹莹 雷蕾 王忠 刘骏 WANG Nian;WANG Bo;LENG Yuanyuan;QI Yifei;LI Bing;ZHANG Yingying;LEI Lei;WANG Zhong;LIU Jun(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处 《中国中医药信息杂志》 CAS CSCD 2022年第12期38-45,共8页 Chinese Journal of Information on Traditional Chinese Medicine
基金 中国中医科学院科技创新工程重大攻关项目(CI2021A05033)。
关键词 冠心病 血瘀证 竞争性内源RNA 长链非编码RNA 调控轴 模块药理学 coronary artery disease blood stasis syndrome ceRNA lncRNA regulatory axis modular pharmacology
  • 相关文献

参考文献6

二级参考文献27

共引文献203

同被引文献29

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部